SST and colorectal carcinoma: Concerning gastrointestinal tract (GIT) tumors, the antitumor activity of SST has been well documented in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) [23,30,31] and poorly in non-endocrine cancers, including sporadic CRC.